Introduction
============

Type V myosins are highly conserved motor proteins that transport organelles, vesicles, proteins, and mRNAs ([@bib58]). They consist of an N-terminal motor domain, followed by a regulatory lever arm and a tail region. The tail contains a coiled-coil region, followed by a short linker and a C-terminal globular tail domain ([Fig. 1 A](#fig1){ref-type="fig"}; [@bib46]). Previous studies suggested that the main function of the globular tail domain is cargo binding ([@bib58]). A recent study in yeast, however, showed that GFP-MS2--tethered messenger ribonucleoprotein particles (mRNPs) are efficiently transported by a globular tail--lacking mutant of the type V myosin Myo4p ([@bib5]).

![**Efficient She3p binding to Myo4p requires the protease-sensitive linker and the globular tail.** (A) Cartoon representation of Myo4p fragments. The full Myo4p tail consists of a coiled-coil region, a linker region, and a sequence stretch with 25% homology to the globular tail of Myo2p. Limited proteolysis experiments with the Myo4p tail fragment revealed a stable cleavage product of 45 kD ([Fig. S1 A](http://www.jcb.org/cgi/content/full/jcb.201002076/DC1)), which was identified as the globular tail. (B) Ni-sepharose pull-down reactions with immobilized His-She3p-N and different Myo4p constructs indicate that the protease-sensitive linker is required for efficient She3p-N binding. (C) Surface-plasmon resonance (SPR) with surface-coupled She3p-N reveals efficient binding of the Myo4p tail, whereas no binding was observed for the globular tail at concentrations up to 5 µM. (D) Pull-down reactions as in B with Myo4p tail in standard buffer (left), buffer containing additional 0.1% Triton X-100 (middle), or buffer containing 1 M NaCl (right). (E) Pull-down reaction as in D with a mutated Myo4p tail fragment (Myo4p-tail (F1056R, I1057R); see A). This fragment failed to reveal binding under standard conditions. (F) Pull-down reactions as in B with GST-Myo4p-L-GT (left), with a globular tail-lacking Myo4p fragment (GST-Myo4p-L; middle), or with a Myo4p fragment that has exchanged its globular tail with the corresponding domain of its paralogue Myo2p (GST-Myo4p-L-Myo2p-GT; right). Dots indicate the position of the respective Myo4p fragments. Note that in the input lane of the middle image, the top band is Myo4p, the middle band is She3p, and the bottom band is a degradation product of Myo4p. (G) SPR with surface-coupled She3p-N reveals efficient binding of the GST-Myo4p-L-GT, whereas no binding was observed even at ∼10 µM when the globular tail was exchanged for the corresponding domain of Myo2p (GST-Myo4p-L-Myo2p-GT).](JCB_201002076_GS_Fig1){#fig1}

Myo4p translocates *ASH1* mRNA plus more than 30 other mRNAs as well as ER into the bud ([@bib36]; [@bib41]). This bud-tip localization of *ASH1* mRNA and the subsequent bud-localized translation of Ash1p prevents mating-type switching exclusively in the bud ([@bib3]; [@bib23]). *ASH1* mRNA localization is a multi-step process that involves (i) nuclear mRNP formation, (ii) assembly of the cytoplasmic transport complex and translational silencing, (iii) Myo4p-dependent mRNP transport to the bud tip, (iv) anchoring at the bud tip and remodeling of the mRNP, and eventually (v) translational activation of *ASH1* mRNA after cytokinesis.

Besides Myo4p itself, mRNA localization depends on its binding partner She3p and the She3p-associated RNA-binding protein She2p ([@bib36]; [@bib41]). Inheritance of cortical ER is independent of She2p and mRNA but still requires the myosin motor and the adapter protein She3p ([@bib13]). Thus, Myo4p interaction with She3p is required for the localization of both cargoes. For this interaction, the N-terminal half of She3p (She3p-N; aa 1--234) binds to two independent regions of the Myo4p tail ([@bib4]; [@bib13]; [@bib19]). The more N-terminal region contains the coiled-coil domain (aa 923--1042; [Fig. 1 A](#fig1){ref-type="fig"}). The C-terminally located She3p-binding region (aa 1042--1471) includes the short linker region and a putative globular tail. Because the globular tail has been reported to be dispensable for in vivo transport of GFP-MS2--tethered reporter mRNAs ([@bib5]), it was suggested that She3p binding is restricted to regions N-terminal of the globular tail. The report further implied that the globular tail might lack functional importance.

In this study we confirmed the correct localization of ER or GFP-MS2--tethered particles upon deletion of the Myo4p globular tail. However, we also found that deletion of the globular tail resulted in impaired She3p binding in vitro. This finding seemed to contradict the previous suggestion that the globular tail might be dispensable for Myo4p-dependent mRNA transport ([@bib5]). We therefore reassessed the potential role of the globular tail of Myo4p in vivo, in vitro, and by x-ray crystallography. Inspection of cells expressing globular tail--lacking Myo4p yielded that mating type switching, as well as Myo4p and *ASH1* mRNA localization, is impaired. These findings indicate that GFP-MS2--tethered particles do not always faithfully recapitulate the endogenous localization of mRNAs.

x-ray structure determination of the Myo4p globular tail yielded significant conservation to the only published structure of a MyoV globular tail (from Myo2p; [@bib43]) and to components of three distinct membrane-tethering complexes. Moreover, residues known from other type V myosins to be important for motor auto-inhibition are lacking in the respective positions on the Myo4p structure. It suggests that Myo4p does not undergo globular tail--dependent auto-inhibition in the previously described fashion.

Results
=======

Defining the domain boundaries of the Myo4p globular tail
---------------------------------------------------------

For a comprehensive analysis of She3p binding to the Myo4p tail, we first identified the boundaries of the globular part of the Myo4p tail by limited proteolysis. After Glu-C protease digestion, we observed a protease-resistant fragment of ∼45 kD ([Fig. S1 A](http://www.jcb.org/cgi/content/full/jcb.201002076/DC1)) starting at aa 1091 ([Fig. 1 A](#fig1){ref-type="fig"}), as identified by Edman sequencing. The experimentally determined approximate boundaries of the globular tail indicate that the Myo4p tail (aa 923--1471) is subdivided into the coiled coil--containing region (aa 923--1041), the globular tail (aa 1091--1471; GT), and a protease-sensitive linker (aa 1042--1090; L) ([Fig. 1 A](#fig1){ref-type="fig"}).

Recent domain-swapping and -deletion experiments showed that C-terminally truncated Myo4p with a stop codon after aa 1068 efficiently localizes large GFP-MS2--tethered *ASH1* mRNA particles as well as ER ([@bib5]). According to our experimental domain mapping, this deletion includes the globular tail plus more than 20 residues of the protease-sensitive linker region. We were interested if a Myo4p fragment with a deletion of the experimentally refined globular tail shows a comparable behavior. We therefore analyzed the localization of GFP-MS2--tethered *ASH1* particles and of ER in response to a Myo4p motor with a stop codon after residue 1090. This truncated motor also localizes GFP-MS2 particles and inherits ER in a manner undistinguishable from full-length Myo4p (Fig. S1, B--F). Thus, our results confirm the previous findings of [@bib5].

The linker in the Myo4p tail is required for efficient She3p binding
--------------------------------------------------------------------

These results suggested that the globular tail might also be dispensable for She3p binding. To directly map the She3p-binding region of Myo4p, we immobilized His-tagged She3p-N on Ni-sepharose beads and performed pull-down experiments with different GST-tagged Myo4p fragments. These fragments contained the globular tail and linker regions of decreasing length, starting from residue 1042 (GST-Myo4p-L-GT), 1063 (GST-Myo4p-L~1/2~-GT), or 1091 (GST-Myo4p-GT), respectively ([Fig. 1 A](#fig1){ref-type="fig"}). The N-terminal fusion of GST ensured dimerization-dependent complex stabilization known to be required for pull-down reactions ([@bib19]). Previous binding studies with GST-Myo4p-L-GT and She3p using surface plasmon resonance (SPR) showed that they interact with an equilibrium-dissociation constant (Kd) of 330 nM ([@bib19]). As expected, an interaction was observed with She3p-N and the GST-Myo4p-L-GT fragment ([Fig. 1 B](#fig1){ref-type="fig"}). In contrast, no significant binding was observed between She3p-N and the GST-Myo4p-L~1/2~-GT or the GST-Myo4p-GT fragment ([Fig. 1 B](#fig1){ref-type="fig"}). Thus, the protease-sensitive linker region in the tail seems important for full She3p binding.

Pull-down experiments often fail to detect weak and/or transient interactions. We therefore tested binding of the Myo4p globular tail fragment by SPR. Also with this method, we detected no interaction of the globular tail with She3p-N, even at 5 µM concentration ([Fig. 1 C](#fig1){ref-type="fig"}).

Sequence analysis of the linker predicted a hydrophobic region between amino acids 1055 and 1060 (Fig. S1 G). Hydrophobic sequence stretches have a high probability to be involved in intra- or intermolecular protein interactions ([@bib56]). Because the linker is highly protease sensitive (Fig. S1 A) and thus might lack a globular fold, we speculated that its hydrophobic amino acids might rather be involved in protein--protein interactions than in local folding events. To test such a hydrophobic contribution in She3p binding, we performed pull-down experiments with She3p-N and the entire Myo4p tail in the presence or absence of a detergent. For this interaction without detergent, a Kd of 172 nM had previously been measured ([@bib19]). As expected, a strong interaction was observed in the previously used buffer conditions ([Fig. 1 D](#fig1){ref-type="fig"}, left; [@bib19]). However, the addition of 0.1% Triton X-100 completely abolished this interaction ([Fig. 1 D](#fig1){ref-type="fig"}, middle). Increasing the ionic strength of a buffer stabilizes hydrophobic interactions, whereas interactions involving charged amino acids are weakened. Pull-down experiments in buffer containing 1 M NaCl still resulted in a considerable binding ([Fig. 1 D](#fig1){ref-type="fig"}, right), suggesting a hydrophobic contribution to the interaction. To find out whether these findings are linked to the hydrophobic patch in the linker, we exchanged the hydrophobic residues phenylalanine in position 1056 and isoleucine in position 1057 in the linker region with arginines (Myo4p-tail (F1056R, I1057R); [Fig. 1 A](#fig1){ref-type="fig"}). Correct overall folding and solubility of this mutant protein was confirmed by size-exclusion chromatography (not depicted). In pull-down experiments, Myo4p-tail (F1056R, I1057R) failed to interact with She3p-N ([Fig. 1 E](#fig1){ref-type="fig"}; positive control in [Fig. 1 D](#fig1){ref-type="fig"}, left). In summary, these results indicate that hydrophobic residues within the linker region of the Myo4p tail contribute to She3p binding.

The Myo4p globular tail is required for efficient She3p binding
---------------------------------------------------------------

To test whether the linker is sufficient for stable complex formation with She3p, we performed pull-down assays with She3p-N and a globular tail--lacking Myo4p fragment (GST-Myo4p-L; [Fig. 1 A](#fig1){ref-type="fig"}). The GST-Myo4p-L fragment could not be pulled down by She3p-N ([Fig. 1 F](#fig1){ref-type="fig"}, middle). However, because we also observed a weak tendency of GST-Myo4p-L to degrade (see degradation band at bottom of [Fig. 1 F](#fig1){ref-type="fig"}, middle) the lack of binding could either mean that the globular tail is required for She3p binding or that it is simply a result of linker degradation.

To assess the latter possibility, we generated a hybrid fragment in which we fused GST-Myo4p-L with the globular tail of the paralogue Myo2p (GST-Myo4p-L-Myo2p-GT; [Fig. 1 A](#fig1){ref-type="fig"}). As expected, the globular tail of Myo2p protected the GST-Myo4p-L fragment from degradation (see input lane in [Fig. 1 F](#fig1){ref-type="fig"}, right). In pull-down experiments, however, GST-Myo4p-L-Myo2p-GT yielded no binding to She3p-N ([Fig. 1 F](#fig1){ref-type="fig"}, right). To detect potential transient interactions that might have escaped detection in pull-down assays, we also tested GST-Myo4p-L-Myo2p-GT in SPR experiments. These SPR experiments failed to show an interaction with immobilized She3p-N, even at a protein concentration of ∼10 µM ([Fig. 1 G](#fig1){ref-type="fig"}). In contrast, the GST-tagged Myo4p fragment consisting of the linker and the endogenous globular tail (GST-Myo4p-L-GT) binds She3p-N with a Kd of 330 nM ([@bib19]) and interacted efficiently with She3p-N in our current experiments ([Fig. 1, B, F, and G](#fig1){ref-type="fig"}). Together, these results indicate that the linker and the globular tail domain provide a composite binding region for She3p.

Deletion of the Myo4p globular tail results in impaired mother cell--specific expression of HO endonuclease
-----------------------------------------------------------------------------------------------------------

The Myo4p globular tail is not required for the localization of GFP-MS2--tethered *ASH1* particles (Fig. S1, D--F; [@bib5]). Our in vitro binding studies, however, point toward a functional requirement of the globular tail for full She3p binding ([Fig. 1, F and G](#fig1){ref-type="fig"}). Because GFP-MS2--tethered reporter particles show clear differences to endogenous particles ([@bib2]; [@bib27]) and because these previous analyses did not include an assessment of correct translation upon localization, we wondered if potential defects could have remained undetected by the GFP-MS2 reporter approach.

We therefore tested the importance of the Myo4p globular tail for the in vivo function of *ASH1*-mRNA localization, i.e., the mother cell--specific expression of HO endonuclease. We used a previously established assay ([@bib23]) in which the promoters of *CAN1* and *ADE2* were replaced with that from the HO endonuclease. Cells with such exchanged promoters accumulate a red-colored pigment under adenine-deficient conditions and become resistant to canavanine whenever the correct localized translation of *ASH1* mRNA fails. As expected, colonies from the *myo4*Δ strain appeared red when grown on plates with reduced adenine levels ([Fig. 2 A](#fig2){ref-type="fig"}), indicating impaired daughter cell--specific Ash1p accumulation. In contrast, wild-type Myo4p-expressing colonies (*MYO4*) showed a white color ([Fig. 2 A](#fig2){ref-type="fig"}). Like *myo4*Δ, the *myo4ΔGT* strain showed a red coloration, indicating a requirement of the globular tail for localized *ASH1*-mRNA translation ([Fig. 2 A](#fig2){ref-type="fig"}). To assess the defect of localized *ASH1*-mRNA translation by canavanine sensitivity, we compared the growth of yeast colonies from these strains on canavanine-containing media. This experiment revealed no detectable difference between the *myo4*Δ and *myo4ΔGT* strains, whereas the growth of *MYO4* cells was reduced ([Fig. 2 B](#fig2){ref-type="fig"}). Thus, the globular tail of Myo4p is not only involved in the She3p interaction in vitro ([Fig. 1, F and G](#fig1){ref-type="fig"}), but also required for correct control of HO expression in vivo.

![**Asymmetric distribution of Ash1 protein.** (A) A white/red assay was used to assess localized *ASH1*-mRNA translation. White color indicates correct asymmetric distribution of Ash1p, whereas a red color indicates defects in this process. As expected, Myo4p knock-out cells show a red color when grown on adenine-deficient media whereas wild-type Myo4p-expressing cells are white. *myo4ΔGT* cells show a red color. (B) On media containing 0.03% canavanine, *myo4Δ* and *myo4ΔGT* cells grow identically, whereas *MYO4* cells show an impaired growth. Both experiments suggest the requirement of the globular tail domain for localized *ASH1*-mRNA translation at the tip of the daughter cell. (C and D) Assessment of Ash1p expression levels in wild-type and *myo4ΔGT* cells by quantitative Western blot. (C) Exemplary Western blot with each sample loaded three times for accurate quantification of Ash1p-Myc and Pgk1p expression levels. (D) The relative expression of Ash1p showed no considerable difference between wild-type and *myo4ΔGT* cells. We normalized the expression of Ash1p relatively to Pgk1p by setting their ratio to one in Myo4p wild-type cells. Three independent experiments were performed for each strain.](JCB_201002076_RGB_Fig2){#fig2}

Ash1p expression levels are not altered in cells expressing globular tail--lacking Myo4p
----------------------------------------------------------------------------------------

Defective control of asymmetric HO-endonuclease expression could be a result of impaired localization and localized translation of *ASH1* mRNA. However, it could also be explained by corrupted translational silencing during otherwise intact transport. It has been described that premature *ASH1*-mRNA translation before anchoring at the bud-tip results in increased Ash1p levels ([@bib17]; [@bib42]; [@bib10]). Thus, if deletion of the globular tail impairs translational repression during transport, we should detect increased expression levels of Ash1p. When we compared the level of Myc-tagged Ash1p by Western blot in *myo4ΔGT* and in wild-type cells (*MYO4*), no significant difference was observed (1.07 ± 0.03-fold of wild-type level; [Fig. 2, C and D](#fig2){ref-type="fig"}). This result rather argues against premature *ASH1* translation upon deletion of the Myo4p globular tail.

The Myo4p globular tail is required for efficient localization of *ASH1* mRNA
-----------------------------------------------------------------------------

To test if a lack of the Myo4p globular tail affects bud-tip localization of *ASH1* mRNA, we generated yeast strains that express Myc-tagged Myo4p or Myc-tagged Myo4p-ΔGT at comparable levels, as confirmed by Western blot analysis (Fig. S1 F). *ASH1* mRNA localization was assessed in dividing cells by in situ hybridization ([Fig. 3 A](#fig3){ref-type="fig"}). In cells expressing wild-type Myo4p, 81.7 ± 4.1% of the cells localized the transcript at the bud tip, 11.1 ± 3.8% in the bud (i.e., bud enriched), and 7.3 ± 0.6% of the cells showed no localization ([Fig. 3 B](#fig3){ref-type="fig"}). In contrast, in Myo4p-ΔGT--expressing cells only 60.0 ± 4.4% of the cells localized *ASH1* mRNA at the bud tip, 25.3 ± 3.2% showed bud enrichment, and 14.7 ± 1.2% yielded no localization ([Fig. 3 B](#fig3){ref-type="fig"}). Cells lacking Myo4p expression showed no *ASH1* mRNA localization (0.0%, not depicted; [@bib35]; [@bib53]). In summary, the results suggest that the defective control of HO expression ([Fig. 2, A and B](#fig2){ref-type="fig"}) is caused by impaired *ASH1* mRNA localization at the bud tip.

![**Myo4p globular tail is required for efficient *ASH1* mRNA and Myo4p localization.** (A) Representative images of mitotic yeast cells stained for *ASH1* mRNA localization by fluorescent in situ hybridization (FISH, left images) and for nuclei by DAPI (right). (B) Graphical representation of the *ASH1* mRNA distribution. Error bars represent the SD from three independent experiments of *n* = 3 × ≥70 cells. The observed differences in bud-tip localization are statistically significant (two-sided *t* test; significance level P = 0.05). (C) Representative images of yeast cells with mid-sized buds that were stained for Myo4p-myc9 (left). Images on the right show DAPI staining. (D) Graphical representation of the Myo4p distribution. Error bars represent the SD from three independent experiments of *n* = 3 × ≥250 cells. Bar (A and C): 4 µm.](JCB_201002076_GS_Fig3){#fig3}

The globular tail is required for correct Myo4p localization at the bud tip
---------------------------------------------------------------------------

We also assessed whether Myc-tagged Myo4p-ΔGT--expressing cells show defects in localization of the motor itself. Myo4p localization was assessed in dividing cells by indirect immunofluorescense microscopy against the Myc tag ([Fig. 3 C](#fig3){ref-type="fig"}). In wild-type cells the motor localized at the bud tip in 30.7 ± 12.0% of all cells and showed a bud-enriched localization in 39.1 ± 6.8% ([Fig. 3 D](#fig3){ref-type="fig"}). In contrast, *myo4pΔGT* cells showed an impaired motor localization with only 8.8 ± 3.8% bud tip localization and 28.3 ± 3.8% bud enrichment ([Fig. 3 D](#fig3){ref-type="fig"}). Thus, the deletion of the Myo4p globular tail also impairs the localization of the motor itself.

Structural analysis of the Myo4p globular tail
----------------------------------------------

The globular tail of Myo4p binds its cargo only in concert with the protease-sensitive linker and the more N-terminal coiled coil--containing region ([@bib19]; [@bib20]), whereas in the paralogue Myo2p cargo binding is mediated by the globular tail itself ([@bib59]). For the globular tail of Myo2p, a high-resolution structure is available ([@bib43]). We reasoned that structural information on the Myo4p globular tail would help to understand the function of this motor protein and that its comparison with the Myo2p structure should provide a sense for the structural conservation among type V myosins. Because both globular tails share only 25% identical amino acids ([Fig. S2](http://www.jcb.org/cgi/content/full/jcb.201002076/DC1)) and because such a low sequence conservation is insufficient to generate trustworthy structural models ([@bib63]), we determined the structure of the Myo4p globular tail by x-ray crystallography.

Crystals grown from the Myo4p globular tail (see Materials and methods) showed high-quality diffraction to 2.3 Å resolution. Because our attempts to obtain phase information by molecular replacement with the globular tail of Myo2p (RCSB Protein Databank ID: [2F6H](2F6H)) as the template failed, we determined the structure by single-wavelength anomalous diffraction using crystals from selenomethionine-derivatized proteins ([Table I](#tbl1){ref-type="table"}). The structure of the Myo4p globular tail (R~work~ = 25.4%; R~free~ = 28.7%) includes aa 1101--1468 and lacks disordered loop regions from residues 1208--1213, 1400--1402, and 1446--1457, as well as the very N-terminal 10 and C-terminal 11 residues.

###### 

Data collection and refinement statistics

  Data collection    Refinement                                            
  ------------------ --------------- ------------ ------------------------ -----------
  x-ray source       ID14-2 (ESRF)   X12 (DESY)                            
  Wavelength (Å)     0.933           0.978        Data range (Å)           96.0--2.3
  Data range (Å)     96--2.3         20--3.2      Reflections F \> 0       36,093
  Observations       286,493         202,888      R~work~                  0.254
      (unique)       (35,353)        (26,406)     (R~free~)                (0.287)
  I/σI               13.2            18.37        RMS bond length (Å)      0.030
      (last shell)   (4.88)          (6.85)       RMS bond angles (deg)    (2.170)
  Completeness (%)   98.1            98.5         Ramachandran plot (%)    
      (last shell)   (94.7)          (95.7)       (allowed)                95.4
                                                  (additionally allowed)   4.4
  R~sym~             0.06            0.11                                  
      (last shell)   (0.38)          (0.29)                                
  R~Cullis~          --              0.823                                 
  Phasing power      --              1.024                                 
  Figure of merit    --              0.362                                 

Cell symmetry: (P2~1~2~1~2~1~) cell constants (Å): a = 43.46, b = 120.99, c = 157.68. R~sym~ is the unweighted R-value on I between symmetry mates. R~work~ = ∑~hkl~ II F~obs~(hkl)I − IF~calc~ (hkl) II/∑~hkl~ I F~obs~ (hkl)I for reflections in the working data set. R~free~ = cross validation R-factor for 5% of reflections against which model was not refined. R~Cullis~ = (phase-integrated lack of closure)/(\|F~PH~ − F~P~\|). Phasing power =\[ \|F~H(Calc)~\|/(phase-integrated lack of closure).

The structure of the Myo4p globular tail has a hook-like shape and is mainly composed of amphipathic α-helices ([Fig. 4 A](#fig4){ref-type="fig"}). It is organized in two globular subdomains, each consisting of an α-helical bundle ([Fig. 4, B and C](#fig4){ref-type="fig"}). Subdomain I reaches from helix H1 to the first half of helix H6. Subdomains I and II are connected by helix H6, which participates with its C-terminal half also in the globular core of subdomain II ([Fig. 4, A--C](#fig4){ref-type="fig"}). In addition, subdomain II comprises a three-helical extension (H11 to H13). From helix H13 the peptide chain loops back along the entire structure to the N terminus, where the C-terminal helix H14 interacts with helices H1 and H2 at the tip of subunit I. A plot of the electrostatic surface potential of the Myo4p globular tail reveals no extensive surface areas with pronounced charges or large hydrophobic patches ([Fig. 4 D](#fig4){ref-type="fig"}).

![**Crystal structure of the Myo4p globular tail.** (A) Cartoon representation of the Myo4p globular tail structure, colored in rainbow representation with the N terminus in blue and C terminus in red. The N and C termini are located next to each other. (B) The Myo4p globular tail, rotated by 180° around the x axis. Subdomain I is highlighted in blue and sub-domain II in red. (C) Topogram of the Myo4p globular tail structure. Colors are the same as in B, except for the loop-connecting helices H13 and H14, which are represented in gray. (D) Surface charge representation of the Myo4p globular tail, with positively and negatively charged areas shown in blue and red, respectively. Cartoon representations were generated with PyMOL (DeLano Scientific LLC), surface charges with CCP4mg ([@bib45]).](JCB_201002076_RGB_Fig4){#fig4}

Myo4p globular tail shows structural similarity to Myo2p and to components of three distinct membrane-tethering complexes
-------------------------------------------------------------------------------------------------------------------------

The crystal structures of the globular tail domains from Myo4p and Myo2p show similar overall folds ([Fig. S3, A--E](http://www.jcb.org/cgi/content/full/jcb.201002076/DC1)). However, the orientation of subdomains I and II relative to each other are different and result in a comparably large root-mean-square deviation (RMSD) of 8.4 Å for their helical regions. Despite their different relative orientations, the individual subdomains I and II from Myo2p and Myo4p have almost identical geometries (Fig. S3, B and C) and RMSD values of 1.5 Å and 3 Å, respectively.

A database search also yielded strong similarity to components of three multi-subunit membrane-tethering complexes (Fig. S3, F--J). This similarity includes the factors Sec6p (PDB-ID: 2FJI, Z-score: 16.0; [@bib52]), Sec15p (PDB-ID: 2A2F, Z-score: 11.3; [@bib61]), and Exo70p (PDB-ID: 2B1E, Z-score: 9.2; [@bib9]) from the exocyst complex, as well as Dsl1p from the Dsl1 membrane tethering complex (PDB-ID: 3K8P, Z-score: 13.8; [@bib48]), and the conserved oligomeric 4 (COG4) factor of the COG complex (PDB-ID: 3HR0, Z-score: 11.1; [@bib49]). Weaker structural similarity was also observed to the exocyst component Exo84p (not depicted; PDB-ID: 2D2S, Z-score: 4.6) and the ER-associated factor GET4 (not depicted; PDB-ID: 2WPV; Z-score: 6.1). The role of these factors in membrane tethering and the localization of exocyst components at the bud tip in yeast ([@bib57]; [@bib60]; [@bib18]) suggests that globular tails of type V myosins could also be involved in the tethering of motors to membranes.

The globular tail of Myo4p lacks a previously described motif for motor auto-inhibition
---------------------------------------------------------------------------------------

One common property of type V myosins is the auto-inhibition of the motor domain by their C-terminal globular tails ([@bib31]; [@bib34]; [@bib55]; [@bib21]). Based on experiments with a heterologous fusion protein, a globular tail--dependent motor inhibition was also proposed for Myo4p ([@bib20]). However, because Myo4p itself is monomeric ([@bib11]; [@bib19]; [@bib20]) and may require oligomerization for processive movement ([@bib11]; [@bib19]), it was also questioned if globular tail--dependent auto-inhibition is indeed used by Myo4p ([@bib19]). In contrast to Myo2p, the structure of the Myo4p globular tail reveals that surface residues involved in auto-inhibition of type V myosins ([@bib32]) are neither conserved in Myo4p or its orthologues ([Fig. S4](http://www.jcb.org/cgi/content/full/jcb.201002076/DC1)), nor are they substituted by nearby residues with similar chemical properties ([Fig. 5 A](#fig5){ref-type="fig"}). Thus, the absence of an auto-inhibition motif renders the known globular tail--dependent inhibition for Myo4p unlikely.

![**Structural conservation of the globular tail of Myo4p.** (A) Residues involved in auto-inhibition of type V myosins by their globular tail ([@bib32]) are conserved in Myo2p (green residues, left) but not in Myo4p (green residues, right), suggesting a lack of auto-inhibition in Myo4p. (B) Surface plot of a sequence alignment from Myo4p, Myo2p, and human Myo5a ([Fig. S2](http://www.jcb.org/cgi/content/full/jcb.201002076/DC1)) show few regions with pronounced sequence identity. Dark yellow indicates residues identical in all three homologues, light yellow shows residues conserved in two homologues, and gray means no conservation. (C) Table showing that surface-exposed residues in Myo4p are much less conserved than buried residues, indicating a lack of conservation of potential binding surfaces.](JCB_201002076_RGB_Fig5){#fig5}

Overall sequence conservation of Myo4p
--------------------------------------

The alignment of the protein sequences (Fig. S2) revealed a low overall conservation between the tails of Myo4p and Myo2p, especially in regions involved in cargo binding by Myo2p (not depicted; [@bib43]). A plot of the sequence alignment from Myo4p, Myo2p, and the human Myo5a (Fig. S2) onto the structure of the Myo4p globular tail ([Fig. 5 B](#fig5){ref-type="fig"}) yielded very little sequence conservation at the surface (3.5% identity; [Fig. 5 C](#fig5){ref-type="fig"}). In contrast, 11.3% of the buried amino acids are identical in all three type V myosins. The lower than average conservation at the surface might be a direct consequence of the different requirements for cargo binding of these motor proteins.

A sequence alignment of the Myo4p globular tail with respective regions of its Myo4p orthologues from *Saccharomyces castellii* and *Candida glabrata* (Fig. S4) and a subsequent surface plot of the alignment onto the Myo4p globular tail structure ([Fig. S5 A](http://www.jcb.org/cgi/content/full/jcb.201002076/DC1)) yielded surface areas of higher sequence conservation. In general, subdomain II showed a higher surface conservation than subdomain I (Fig. S4: compare residues 1101--1245 with residues 1270--1445; Fig. S5 A). On the surface plot, we recognized a conserved patch in subdomain II with surface-exposed tryptophane and tyrosine residues (Fig. S5, B and C).

Point mutations in the globular tail impair She3p interaction in vitro
----------------------------------------------------------------------

Because tryptophans and tyrosines on protein surfaces have been reported to have an above average probability to participate in stable protein--protein interactions ([@bib24]), we reasoned that they may play a functional role in She3p association. To test whether this surface patch is important for She3p interaction, we generated a Myo4p globular tail with tryptophan in position 1325 and tyrosine in position 1329 substituted with glutamic acid (GST-Myo4p-L-GT-(W1325D, Y1329D); [Fig. 6 A](#fig6){ref-type="fig"}). We also generated a second double mutant in close proximity to the described patch, where we exchanged the two surface-exposed hydrophobic residues leucine in position 1365 and isoleucine in position 1367 against glycine (GST-Myo4p-L-GT-(L1365G, I1367G); [Fig. 6 A](#fig6){ref-type="fig"} and Fig. S5, B and C). Correct folding of both double mutants was assessed by size-exclusion chromatography and circular dichroism spectroscopy (Fig. S5 D).

![**Point mutants in the globular tail and the linker region of Myo4p impair She3p binding and *ASH1* mRNA localization.** (A) Cartoon representation of Myo4p fragments containing point mutations. Representation is identical to [Fig. 1 A](#fig1){ref-type="fig"}. (B) Ni-sepharose pull-down reactions with immobilized His-She3p-N and point-mutated Myo4p fragments. Whereas both Myo4p fragments with double point mutations in their globular tail showed no detectable interaction (right), the same Myo4p fragment without point mutations yielded significant binding (left). (C) Graphical representation of the *ASH1* mRNA localization in *myo4Δ* cells, rescued by the expression of either wild-type Myo4p or its mutant forms Myo4p-(W1325D,Y1329D) and Myo4p-(F1056R,I1057R). *ASH1* mRNA localization is the same as in [Fig. 3, A and B](#fig3){ref-type="fig"}. Both mutants show statistically significant defects in bud-tip localization (two sided *t*-test; significance level P = 0.05). SDs are derived from three independent experiments of *n* = 3 × ≥50 cells (total \>200 cells per construct).](JCB_201002076_GS_Fig6){#fig6}

To test whether these mutants are important for the binding of Myo4p to She3p, we repeated pull-down experiments with GST-Myo4p-L-GT and the mutated derivatives of this fragment. Whereas GST-Myo4p-L-GT showed the expected strong interaction ([Fig. 6 B](#fig6){ref-type="fig"}; see also [Fig. 1, B, F, and G](#fig1){ref-type="fig"}), neither GST-Myo4p-L-GT-(W1325D, Y1329D) nor GST-Myo4p-L-GT-(L1365G, I1367G) yielded any detectable binding in pull-down experiments ([Fig. 6 B](#fig6){ref-type="fig"}). Thus, both point mutants impair the interaction with She3p in vitro, providing additional evidence that the globular tail is important for She3p binding.

Point mutations in the globular tail and in the linker region impair localization of *ASH1* mRNA
------------------------------------------------------------------------------------------------

Our in vitro pull-down experiments revealed that the double mutation F1056R, I1057R in the protease-sensitive linker region ([Fig. 1, A and E](#fig1){ref-type="fig"}) and the double mutations in the globular tail ([Fig. 6, A and B](#fig6){ref-type="fig"}) impair the interaction with She3p. To test whether both types of mutations also impair *ASH1* mRNA localization in vivo, we expressed plasmid-encoded full-length Myo4p with the respective double mutations in *myo4Δ* background in yeast and assessed *ASH1* mRNA localization by in situ hybridization. In 78.9 ± 6.5% of the wild-type Myo4p-expressing cells the *ASH1* mRNA was localized at the bud tip, whereas in 14.9 ± 5.0% of these cells *ASH1* mRNA accumulated in the bud (6.0 ± 1.7% showed no localization; [Fig. 6 C](#fig6){ref-type="fig"}). Mutations in the Myo4p linker region (Myo4p-(F1056R, I1057R)) resulted in reduced bud tip and bud localization of the *ASH1* mRNA (61.3 ± 4.2% and 21.3 ± 3.2%, respectively; 17.3 ± 2.5% showed no localization). This distribution is similar to the situation in cells with mutations in the globular tail (Myo4p-(W1325D, Y1329D)), which results in *ASH1*-mRNA localization at the bud tip in 55.7 ± 2.1% of all cells (20.3 ± 4.7% bud localization and 24.0 ± 3.0% without localization; [Fig. 6 C](#fig6){ref-type="fig"}). Cells transfected with an empty vector (mock control) did not localize *ASH1* mRNA to the bud tip (not depicted). Although the experimental setup was not identical, the *ASH1* mRNA localization defects observed with Myo4p-(F1056R, I1057R) and Myo4p-(W1325D, Y1329D) expressed from plasmids are similar to the defects observed for a genomically expressed Myo4p fragment lacking the entire globular tail ([Fig. 3, A and B](#fig3){ref-type="fig"}). In summary, these results confirm the defects in She3p binding and demonstrate that both the linker and the globular tail play a role in *ASH1* mRNA transport. The moderate defects are consistent with previous findings that She3p binding by this C-terminal interaction region is to some extent redundant with the more N-terminal coiled coil--containing interaction region ([@bib19]; [@bib20]).

Discussion
==========

A recent study showed that the globular tail of Myo4p is not required for the localization of GFP-MS2--tethered particles to the bud and for the inheritance of ER ([@bib5]). This observation suggested that the globular tail might be dispensable for the localization of endogenous *ASH1* mRNA and thus also for inhibition of mating type switching in the daughter cell. It further raised the question of whether the globular tail of Myo4p has any function. Here, we used an experimentally refined, globular tail--lacking Myo4p to confirm the previous findings from [@bib5] (Fig. S1, A--F).

However, when analyzing mother cell--specific expression of the HO endonuclease in cells expressing a globular tail--lacking Myo4p fragment, we found that this process is impaired ([Fig. 2, A and B](#fig2){ref-type="fig"}). The subsequent analysis of *ASH1* mRNA localization by in situ hybridization and of Myo4p localization by immunofluorescence staining consistently showed that the globular tail is required for full Myo4p activity in vivo ([Fig. 3](#fig3){ref-type="fig"}). In vitro interaction studies with different Myo4p fragments and its adapter She3p also demonstrated that the globular tail is required for efficient complex formation ([Fig. 1 A,F,G](#fig1){ref-type="fig"}). Analysis of surface features of the Myo4p globular tail and subsequent mutational studies identified a set of mutations in the globular tail that impairs She3p binding in vitro and reduces *ASH1* mRNA localization in vivo ([Fig. 6](#fig6){ref-type="fig"} and Fig. S5, A--D). Furthermore, the protease-sensitive linker between the coiled-coil region and the globular tail contains a hydrophobic sequence patch that, upon mutation, also results in impaired She3p binding and reduced *ASH1* mRNA localization ([Fig. 1 E](#fig1){ref-type="fig"} and [Fig. 6 C](#fig6){ref-type="fig"}). Thus, deletion studies as well as point mutations in the linker region and in the globular tail confirm the requirement of both regions for She3p binding and Myo4p function. An obvious question arising from these findings is why two independent groups (this study and [@bib5]) were unable to detect this localization defect by analyzing RNA localization with GFP-MS2--tethered particles.

It has been reported that insertion of MS2-stem loops into the 3′ UTR of *ASH1* mRNA and the tethering of multiple GFP-MS2 molecules to the 3′ UTR reduces the number of *ASH1* transport particles and increases their size ([@bib2]; [@bib27]). This effect is particularly pronounced when the reporter RNA is expressed from a strong *GAL1* promoter. In the majority of cases, we detected only a single large particle per cell (see Fig. S1 D), whereas normal cells contain several *ASH1*-mRNA particles, even when *ASH1* mRNA is overexpressed ([@bib27]). In light of these considerations, our findings indicate that GFP-MS2--tethered particles may not always faithfully recapitulate endogenous *ASH1* mRNA localization. This technical limitation might be particularly true for defects that do not result in a total loss of *ASH1* mRNA localization, like the deletion of the globular tail studied here.

For ER inheritance, moderately impaired Myo4p-dependent transport may also not result in detectable differences. Certain aspects of Myo4p function differ for *ASH1* mRNA localization function. For *ASH1* mRNA localization, the motor Myo4p, full-length She3p, the RNA-binding protein She2p, as well as a number of additional RNA-binding factors are required; in contrast, Myo4p and the N-terminal domain of She3p are sufficient for ER inheritance ([@bib13]; [@bib50]). In addition, cortical ER is tethered to the Myo4p--She3p complex by an unknown mechanism and its inheritance does not seem to require an anchoring step at the bud tip. It has also been disputed how important the contribution of Myo4p to ER inheritance is ([@bib47]). Finally, it should be noted that ER inheritance is happening early in the cell cycle, before *ASH1* mRNA is expressed and localized. In summary, there are several differences between ER inheritance and *ASH1* mRNA localization that could explain the lacking defect in ER inheritance. More molecular details of ER inheritance may be required to understand the mechanistic basis of this difference.

The x-ray structure of the Myo4p globular tail revealed an almost entirely α-helical domain with a hook-like arrangement. The sequence identity between the globular tails of Myo4p and Myo2p is only 25% (Fig. S2). It is therefore remarkable that both domains share a very similar structural arrangement, composed of two almost identical subdomains. Considering the very different functions of Myo2p and Myo4p, and the low sequence identity for their globular tails, it is possible that similar domain architectures are also present in globular tail domains of other type V myosins. The extremely low surface conservation indicates that these domains evolved significantly diverging surface properties to allow for the binding of very different cargoes or cargo adapters.

However, when superposing the globular tails of Myo4p and Myo2p, we found that the surface region of Myo4p required for She3p binding (Fig. S5, B and C) overlaps with residues in Myo2p important for peroxisome inheritance and interaction with its peroxisome cargo adapter Inp2p. (Fig. S5, E and F; [@bib14]). This surface is also required for the interaction of Myo2p with the Rab GTPases Ypt31/32 and motility of endocytic compartments ([@bib33]). These structural overlaps suggest that at least some type V myosins might have a common functional site in their globular tail, albeit with different cargo specificities.

Our structural analyses also revealed that the Myo4p globular tail lacks residues conserved in other MyoV motors ([Fig. 5 A](#fig5){ref-type="fig"}; Figs. S2 and S4) that are required for auto-inhibition of their motor domains. The lacking conservation of this surface area suggests that Myo4p does not undergo auto-inhibition by the previously described mechanism ([@bib32]). Because Myo4p is strictly monomeric in absence of cargo complexes ([@bib11]; [@bib19]; [@bib20]) and may require oligomerization for processive movement ([@bib11]; [@bib19]), such an auto-inhibition mechanism might indeed not be required.

Database searches yielded strong structural similarity of the globular tails of Myo4p and Myo2p to components of the membrane-tethering exocyst, Dsl1 and COG complexes (Fig. S3, D--I). The role of these factors in membrane tethering and the localization of exocyst components at the bud tip in yeast ([@bib57]; [@bib60]; [@bib18]) suggest that MyoV globular tails could potentially also tether to membrane sites.

All exocyst components with known structures share a similar overall fold ([@bib39]). Because these exocyst components are thought to interact with each other through their elongated helical bundles ([@bib9]), a similar interaction with exocyst components could also be envisioned for the structurally related MyoV globular tails. However, immunoprecipitation experiments with the globular tail of Myo4p failed to yield an interaction with the exocyst components Sec3p, Sec5p, Sec6p, Sec10p, Sec15p, Exo70p, or Exo84p above background levels (unpublished data). Because interaction studies with membrane-associated complexes are often technically demanding, it might be that experimental limitations prevented us from detecting binding to the exocyst complex. More thorough experiments will be required to rigorously assess the functional relationship of exocyst components and the Myo4p globular tail.

Regardless of this preliminary result, it will be interesting to see if globular tails of other MyoV motors can interact with exocyst components. The most pronounced difference between the Myo2p and Myo4p globular tails is the relative arrangement of their subdomains I and II and their resulting different overall shapes. In case a subset of MyoV globular tails indeed binds to exocyst components, such a difference in subdomain orientation could influence their propensity to interact with the elongated helical bundles of the exocyst complex.

In type V myosins of higher eukaryotes, regions outside the globular tail also contribute to binding of cargo complexes ([@bib30]). For instance, vertebrate Myo5a interacts with its adapter melanophilin through the globular tail and a more N-terminal motif in the rod region ([@bib62]). A second example is Myo5b, where also a motif in the rod and in the globular tail has been suggested to mediate binding to its Rab11--FIP2 cargo complex ([@bib29]). These binding motifs outside the globular tail are only found in alternatively spliced, tissue-specific versions of Myo5a/b, whereas their other splice forms bind to different cargo complexes ([@bib30]). In yeast, Myo2p and Myo4p exist only as a single isoform. Based on sequence identity (Fig. S2 B), dimerization state ([@bib11]; [@bib19]; [@bib20]), and the presence of an auto-inhibition motif in the globular tail ([Fig. 5 A](#fig5){ref-type="fig"}), Myo2p is arguably the closer homologue to MyoV from vertebrates. However, only Myo4p binds its cargo in a way reminiscent of the alternatively spliced Myo5a and Myo5b motors. In summary, we find that the generally assumed requirement of the globular tail in type V myosins for cargo binding also holds true for Myo4p from yeast.

Materials and methods
=====================

Yeast strains
-------------

General methods to culture and manipulate yeast strains were performed as described previously ([@bib15]; [@bib1]; [@bib16]). All strains were derived from Y18 ([@bib50]), Y28 ([@bib23]), or Y56 ([@bib3]) either by transformation with the corresponding plasmids or homologous recombination ([@bib22]). Detailed information on strains and plasmids is provided in [Tables II--IV](#tbl2){ref-type="table"}[](#tbl3){ref-type="table"}[](#tbl4){ref-type="table"}.

###### 

Plasmids

  Name                       Insert                          Vector      Template                Primer              Enzyme              Source
  -------------------------- ------------------------------- ----------- ----------------------- ------------------- ------------------- ------------
  ***E. coli* expression**                                                                                                               
  P2                         She3p-N                         pET 28a     genomic DNA             O6/O7               BamH1--Xho1         ([@bib19])
  P7                         Myo4p tail                      pGEX-6P-1   *genomic DNA*           O2/O4               BamH1--Xho1         ([@bib19])
  P10                        Myo4p-L-GT                      pGEX-6P-1   *genomic DNA*           O5/O4               BamH1--Xho1         This study
  P22                        Myo4p-GT                        pGEX-6P-1   *genomic DNA*           O13/O4              BamH1--Xho1         This study
  P21                        Myo4p-L~1/2~-GT                 pGEX-6P-1   *P10*                   O14/O4              BamH1--Xho1         This study
  P134                       Myo4p tail~(F1056R,\ I1057R)~   pGEX-6P-1   *genomic DNA*           O2/O4/O98/O99       Nde1--Spe1          This study
  P201                       GST-Myo4p-L-Myo2p-GT            pGEX-6P-1   *genomic DNA*           O5/O86/O252/O253    BamH1--Xho1         This study
  P204                       GST-Myo4p-L                     pGEX-6P-1   *genomic DNA*           O5/O251             BamH1--Xho1         This study
  P205                       GST-Myo4p-L-GT~W1325D,Y1329D~   pGEX-6P-1   *genomic DNA*           O5/O4/O165/O166     BamH1--Xho1         This study
  P206                       GST-Myo4p-L-GT~L1365G-I1367G~   pGEX-6P-1   *genomic DNA*           O5/O4/O258/O259     BamH1--Xho1         This study
  **Yeast transformation**                                                                                                               
  P45                        p414-GAL1-Myo4 922-1472                                                                                     ([@bib19])
  P46                        YCp22                                                                                                       ([@bib16])
  P137                       Myo4p                           YCp22       *genomic DNA and P45*   O4/O110/O132/O134   Kpn1--Hind3--Spe1   This study
  P145                       Myo4p-~W1325D,Y1329D~-          YCp22       *P137*                  O98/O99                                 This study
  *P179*                     Myo4p-~F1056R,\ I1057R~         YCp22       *P137*                  O165/O166                               This study
  P194                       pUG34-yeGFP3-2xNLS-lambda                                                                                   ([@bib27])
  P195                       p414 GAL1-ASH1-6xBoxB                                                                                       ([@bib27])

###### 

Oligonucleotides

  Name       Primer for biochemical characterization
  ---------- ---------------------------------------------------------------------------------------------------
  O2         5′ aaa gga tcc aag caa agg caa gag tac g 3′
  O4         5′ aaa ctc gag tta ttt tct gtc taa ttt tat aat 3′
  O5         5′ aaa gga tcc aga tta agt gat gaa gtc aaa 3′
  O6         5′ aaa gga tcc atg tcg gac cag gat aat acc 3′
  O7         5′ gga ctc gag tta ctt gct taa ttt tga 3′
  O13        5′ aaa gga tcc cta gtc aat gta att cgt aga 3′
  O14        5′ aaa gga tcc caa gat ttc acc acc aca tat 3′
  O98        5′ aag caa gaa cta gcg cga cga gaa aac gta ata 3′
  O99        5′ tat tac gtt ttc tcg tcg cgc tag ttc ttg ctt 3′
  O86        5′ gca ctc gag tta gtg gcc gtc ttg aac gac 3′
  O110       5′ cat ttg ttc aac ttg tgc cgt ctt cag ctt gga 3′
  O132       5′ aaa ggt acc ctg cag taa cag tta ggg cta ttc t 3′
  O134       5′ gcc gcg gcc gca agc tta aga cat agc aag cgc aac gta tt 3′
  O165       5′ tgt ccc gcg tta aat gat aag tat ggg gat gaa gtg gat aga aat 3′
  O166       5′ att tct atc cac ttc atc ccc ata ctt atc att taa cgc ggg aca 3′
  O251       5′ gca ctc gag tta ctt cgg ttt tac ttg ttg tcc 3′
  O252       5′ gac aac aag taa aac cga agg tcg atc gcg aaa atg gtg tc 3′
  O253       5′ gac acc att ttc gcg atc gac ctt cgg ttt tac ttg ttg tc 3′
  O258       5′ gtc aag ata tta cag gga aag gga agc aac ttg aac gag 3′
  O259       5′ ctc gtt caa gtt gct tcc ctt tcc ctg taa tat ctt gac 3′
  **Name**   **Primer used for homologous recombination in yeast**
  O195       5′ atg ata aag tga aag gtt tgg gaa tcg cag gac aac aag taa aac cga agc gta cgc tgc agg tcg ac 3′
  O196       5′ ata cag agg gct tag cta ctg tag taa aat tat aaa att aga cag aaa acg tac gct gca ggt cga c 3′
  O197       5′ tat atg tat ata tac ata tat aca tat atg ggc gta tat tta ctt tgt tca tcg atg aat tcg agc tcg 3′
  O208       5′ ttg atg ttg tcg cta cta aat ggc atg aca aat ttg gta aat tga aaa acc gta cgc tgc agg tcg ac 3′
  O209       5′ tat taa cta gtg gta ctt att tgc tct ttt tga gct aaa aac tga agg cca tcg atg aat tcg agc tcg 3′

###### 

Yeast strains

  Strain   Essential genotype                                                                                                     Source
  -------- ---------------------------------------------------------------------------------------------------------------------- ------------
  Y18      *MAT a; URA3::HMG1-GFP*                                                                                                ([@bib50])
  Y21      *MAT a; URA3::HMG1-GFP; HIS3::MYO4-9Myc*                                                                               This study
  Y22      *MAT a: URA3::HMG1-GFP; HIS3::MYO4-1090stop-9Myc*                                                                      This study
  Y28      *MAT a; trp1-1; leu2-3; his3-11; ura3; ade2-1; HO-ADE2, HO-CAN1*                                                       ([@bib23])
  Y29      *MAT a; trp1-1; leu2-3; his3-11; ura3; ade2-1; HO-ADE2, HO-CAN1, HIS3::MYO4-9Myc*                                      This study
  Y30      *MAT a; trp1-1; leu2-3; his3-11; ura3; ade2-1; HO-ADE2, HO-CAN1; HIS3::MYO4-1090stop-9Myc*                             This study
  Y32      *MAT a; trp1-1; leu2-3; his3-11; leu; ura3; ade2-1; HO-ADE2, HO-CAN1; MYO4::URA3*                                      ([@bib23])
  Y35      *MAT a; trp1-1; leu2-3; his3-11; leu; ura3; ade2-1; HO-ADE2, HO-CAN1; MYO4::URA3; P46::TRP*                            This study
  Y38      *MAT a; trp1-1; leu2-3; his3-11; leu; ura3; ade2-1; HO-ADE2, HO-CAN1; MYO4::URA3; P137::TRP*                           This study
  Y39      *MAT a; trp1-1; leu2-3; his3-11; leu; ura3; ade2-1; HO-ADE2, HO-CAN1; MYO4::URA3; P179::TRP*                           This study
  *Y53*    *MAT a; trp1-1; leu2-3; his3-11; ura3; ade2-1; HO-ADE2, HO-CAN1, CloNat::MYO4-9Myc, HIS:: P194, TRP:: P195*            This study
  *Y55*    *MAT a; trp1-1; leu2-3; his3-11; ura3; ade2-1; HO-ADE2, HO-CAN1, CloNat::MYO4-1090stop-9Myc, HIS:: P194, TRP:: P195*   This study
  Y56      *MAT a; trp1-1; leu2-3; his3-11; ura3; ade2-1; HO-ADE2, HO-CAN1, ASH1-myc9*                                            ([@bib3])
  Y58      *MAT a; trp1-1; leu2-3; his3-11; ura3; ade2-1; HO-ADE2, HO-CAN1, ASH1-myc9, CloNat::MYO4-1090stop-6HA*                 This study
  Y59      *MAT a; trp1-1; leu2-3; his3-11; leu; ura3; ade2-1; HO-ADE2, HO-CAN1; MYO4::URA3; P145::TRP*                           This study

Yeast growth conditions
-----------------------

For ER and motor localization, cells were grown in the appropriate selective minimal medium ([@bib1]). For the assessment of asymmetric Ash1p distribution or of localization of *ASH1* mRNPs, cells were plated on appropriate selective minimal medium containing 5 mg/l adenine, 4% glucose or 2% raffinose and 80 mg/ml methionine, respectively. Expression of MS2-tagged *ASH1* mRNAs was induced by diluting cells in selective medium containing 2% galactose and subsequent growth for 1 h. For induction of the GFP-λN-peptide expression, cells were washed with selective medium lacking methionine and incubated for one additional hour.

FISH and indirect immunofluorescence
------------------------------------

FISH against *ASH1* mRNA with digoxigenin-labeled antisense RNA and indirect immunofluorescence against myc-tagged Myo4p was performed as described in [@bib38]. After mounting in 80% glycerol, cells were inspected using a CellObserver epifluorescence microscope (Carl Zeiss, Inc.) equipped with a Lambda DG-4 light source (Sutter Instrument Co.) and a PZ2000 piezo-driven stage (Applied Scientific Instruments). Images were acquired with a CCD camera (MRm Rev.3; Carl Zeiss, Inc.) controlled by AxioVision 4.7 software (Carl Zeiss, Inc.). For each cell, image stacks of 30 images at a 0.2-µm distance were acquired. Stacks were subsequently processed to remove out-of-focus haze using the integrated deconvolution software package of the AxioVision software. After deconvolution, the 20 central images were projected into one plane.

Immunofluorescence microscopy
-----------------------------

Indirect immunofluorescence against Myc-tagged proteins was essentially performed as described previously ([@bib4]; [@bib26]). Spheroplasts were sequentially incubated with mouse anti-Myc antibody (Roche) and goat anti--mouse IgG coupled to Alexa Fluor 594 (Invitrogen). Nuclei were stained with Hoechst stain solution (Sigma-Aldrich) and cells were mounted in 80% glycerol. For visualization of GFP fusion proteins, cells were fixed with paraformaldehyde. Cells were inspected at room temperature with a 100 NA 1.3 DIC oil objective using either a fluorescence microscope (model BX60; Olympus) with a CCD camera (ORCA ER; Hamamatsu Photonics) controlled by Openlab 4 software (PerkinElmer), or the Leica AF6000LX system (microscope, DMI6000 B; camera, DFC350FX; software: LAS AF). All localization experiments were performed three times by inspecting cells of medium-sized buds (2-µm diameter).

Western blot against Ash1p-Myc
------------------------------

Total protein was extracted from 10 OD~600~ units of logarithmically growing cells. After determination of the linear detection range of the antibodies and the cell lysates ([@bib7]), 80 OD~280~ units of lysate were used for Western blot analysis of Ash1p-Myc with mouse anti-Myc antibody (Roche) and Pgk1p using mouse anti-Pgk1 antibody (Invitrogen). Signals were detected by chemiluminescence using a Fujifilm LAS-3000 mini system and integrated using the Multi Gauge software (Fujifilm) with background subtraction.

Protein purification and crystallization
----------------------------------------

GST-tagged myosin fragments and His-tagged She3p-N were expressed in *Escherichia coli* and isolated to a purity of ≥95% using standard chromatographic techniques ([@bib19]). GST tags were removed by protease cleavage ([@bib37]), unless stated otherwise. Crystals were grown at 21°C by hanging-drop vapor-diffusion using a 1:1 mixture of protein (12--20 mg/ml) and crystallization solution containing 100 mM Hepes, pH 8.5, 20% PEG 3350, 150 mM HCO~2~Na, and 10 mM K~2~Pt(CN)~4~ for native crystals and 100 mM Hepes, pH 8.5, 20% PEG 3350, and 150 mM HCO~2~Na for selenomethionine (SeMet) substituted crystals. Crystals appeared within 24 h.

Structure determination
-----------------------

Cryoprotection was achieved by adding 20% ethylene glycol. Native data were recorded at ID14-1 (European Synchrotron Radiation Facility, France), integrated and scaled using Mosflm and SCALA ([@bib8]). Single-wavelength anomalous diffraction (SAD) experiments were recorded at beamline X12 (Deutsches Elektronen-Synchrotron \[DESY\], Germany), integrated and scaled using XDS ([@bib25]). 14 selenium atoms were located with SHELXD ([@bib51]), phases obtained with SHARP ([@bib6]), and extended to 2.3 Å. After partial automatic model building with ARP/wARP ([@bib28]) the structure was manually completed using COOT ([@bib12]). Refinement was performed with Refmac ([@bib40]; [@bib54]), using non-crystallographic symmetry. The final model was analyzed using SFCHECK. Protein Databank ID: [3MMI](3MMI).

Ni pull-down
------------

Pull-down experiments were essentially performed as described previously ([@bib19]). 50 µg of both proteins were incubated with 50 µl of Ni-Sepharose for 1 h in 20 mM Tris-HCl, pH 7.5, 200 mM NaCl, and 15 mM imidazole. Sepharose was washed five times with 200 µl reaction buffer, followed by a final wash step with 50 µl. Proteins were eluted with 50 µl buffer containing 20 mM Tris-HCl, pH 7.5, 200 mM NaCl, and 750 mM imidazole. For visualization, 1/10 of the input, 1/5 of the final wash, and 1/5 of the elution fraction was analyzed by SDS-PAGE and Coomassie staining.

Surface plasmon resonance
-------------------------

Experiments were performed using a Biacore 3000 system (GE Healthcare) with She3p-N bound to a CM5 chip surface (standard amine coupling: ≤200 RU). The Myo4p fragments were applied in running buffer (10 mM Hepes, pH 7.5, 200 mM NaCl, and 50 mM EDTA) with a concentration range from 1 µM to 10 µM.

Bioinformatics
--------------

Sequence alignments were performed with JPred ([www.compbio.dundee.ac.uk/∼www-jpred/](www.compbio.dundee.ac.uk/~www-jpred/)) and visualized with the program CLC-free-workbench (CLCbio). Physical and chemical parameters of recombinant proteins were calculated with the program ProtParam, and the hydrophobicity prediction by the program ProtScale, using the Kyte--Doolittle amino acid scale. All programs are available via the ExPASy proteomics server (<http://www.expasy.org/>). Superposition of two homologous structures and RMSD calculation was performed with LSQMAN (<http://xray.bmc.uu.se/usf/>). Calculation and representation of the electrostatic surface was done with CCP4mg. Images of the crystal structures were prepared with PyMOL (DeLano Scientific LLC) and Chimera ([@bib44]). *t* - test was performed with the program Statistica 7.1 (StatSoft).

Online supplemental material
----------------------------

Fig. S1 shows that the Myo4p globular tail is dispensable for ER inheritance and localization of MS2-GFP reporter particles. Fig. S2 contains a sequence alignment of different MyoV globular tails. Fig. S3 shows the structural similarity of the Myo4p globular tail to membrane-tethering complexes. Fig. S4 shows a sequence alignment of Myo4p orthologues from different yeast species. Fig. S5 shows structural details and mutations in the globular tails of Myo4p and Myo2p. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.201002076/DC1>.
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